Potential ALS Therapy Based on Cancer Treatment Rituximab Shows Promise

Potential ALS Therapy Based on Cancer Treatment Rituximab Shows Promise

Researchers at Ben-Gurion University (BGU) believe that an existing FDA-approved anti-cancer drug, rituximab, could be modified and used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. In lab studies with mice, the therapy restored resident immune cells of the central nervous system, which could indicate…

Do Firefighters Have an Increased Risk of Developing ALS?

As part of ALS Awareness Month, we’re looking at some of the research into ALS and which populations are more likely to develop the disease. Over the years, researchers have focused on the connection between firefighters and various diseases, including cancer and heart disease, but recent studies have shown that firefighters are more…